The stock of Skyline Medical Inc (NASDAQ:SKLN) is a huge mover today! About 254,974 shares traded hands. Skyline Medical Inc (NASDAQ:SKLN) has declined 38.50% since April 13, 2016 and is downtrending. It has underperformed by 42.42% the S&P500.
The move comes after 7 months negative chart setup for the $7.43M company. It was reported on Nov, 15 by Barchart.com. We have $2.20 PT which if reached, will make NASDAQ:SKLN worth $891,600 less.
Analysts await Skyline Medical Inc (NASDAQ:SKLN) to report earnings on November, 21.
According to Zacks Investment Research, “Skyline Medical Inc. is a medical device company. It produces an automated surgical fluid disposal system. The Company has a fully automated surgical fluid disposal device – the Streamway System. Its Streamway System fully automates the collection, measurement and disposal of surgical fluids. Skyline Medical, Inc. is based in Eagan, Minnesota.”
Another recent and important Skyline Medical Inc (NASDAQ:SKLN) news was published by Globenewswire.com which published an article titled: “Skyline Medical Announces all Three Proposals Approved at Special Meeting of …” on September 16, 2016.
SKLN Company Profile
Skyline Medical Inc., incorporated on April 23, 2002, is a medical device firm that develops and makes The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Firm distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed. The Firm also makes and sells two disposable products required for system operation: a bifurcated single procedure filter and tissue trap, and a single use bottle of cleaning solution. Both items are used on a single procedure basis.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.